Aeglea Bio Therapeutics Inc (AGLE) Insider Trading
- $6,868,573.37
- $962,614.88
- Aug. 25, 2022
- Anthony G Quinn
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 25, 2022 | Director | 90,000 | $0.56 | Buy | $50,400.00 | |
| March 16, 2022 | CEO | 80,079 | $2.34 | Buy | $187,384.86 | |
| March 14, 2022 | CEO | 67,472 | $1.93 | Buy | $130,220.96 | |
| March 11, 2022 | CFO | 75,000 | $2.08 | Buy | $156,000.00 | |
| March 11, 2022 | CEO | 34,777 | $2.06 | Buy | $71,640.62 | |
| Dec. 13, 2021 | Director | 14,685 | $3.65 | Buy | $53,600.25 | |
| Dec. 9, 2021 | Director | 121,799 | $3.67 | Buy | $447,002.33 | |
| Dec. 9, 2021 | CFO | 50,000 | $3.72 | Buy | $186,000.00 | |
| Dec. 9, 2021 | CEO | 43,108 | $3.70 | Buy | $159,499.60 | |
| Aug. 18, 2021 | CFO | 7,200 | $6.72 | Buy | $48,384.00 | |
| Aug. 16, 2021 | CFO | 9,780 | $6.37 | Buy | $62,298.60 | |
| April 30, 2020 | CEO | 165,000 | $4.75 | Buy | $783,750.00 | |
| June 14, 2019 | CEO | 31,905 | $6.16 | Buy | $196,534.80 | |
| June 12, 2019 | CEO | 12,217 | $6.11 | Buy | $74,645.87 | |
| May 22, 2019 | CEO | 26,592 | $6.77 | Buy | $180,027.84 | |
| May 20, 2019 | CEO | 8,989 | $6.56 | Buy | $58,967.84 | |
| May 17, 2019 | CEO | 6,218 | $6.65 | Buy | $41,349.70 | |
| May 15, 2019 | CEO | 6,256 | $6.76 | Buy | $42,290.56 | |
| Feb. 15, 2019 | CEO | 719 | $7.10 | Buy | $5,104.90 | |
| Sept. 27, 2018 | Insider | 6,000 | $9.50 | Sell | $57,000.00 | |
| May 10, 2018 | Major Shareholder | 73,955 | $10.12 | Sell | $748,424.60 | |
| May 7, 2018 | Major Shareholder | 15,548 | $10.11 | Sell | $157,190.28 | |
| Dec. 8, 2017 | CEO | 8,288 | $4.96 | Buy | $41,108.48 | |
| Dec. 6, 2017 | CEO | 4,888 | $4.92 | Buy | $24,048.96 | |
| Dec. 5, 2017 | CFO | 25,959 | $4.48 | Buy | $116,296.32 | |
| Dec. 4, 2017 | Director | 7,956 | $4.98 | Buy | $39,620.88 | |
| Dec. 1, 2017 | Director | 4,100 | $4.53 | Buy | $18,573.00 | |
| Dec. 1, 2017 | CFO | 6,500 | $4.59 | Buy | $29,835.00 | |
| Feb. 21, 2017 | Major Shareholder | 109,300 | $5.16 | Buy | $563,988.00 | |
| April 12, 2016 | Director | 10,000 | $10.00 | Buy | $100,000.00 | |
| April 12, 2016 | Major Shareholder | 300,000 | $10.00 | Buy | $3,000,000.00 |
Insiders are both buying and selling Aeglea Bio Therapeutics Inc stock.
The insider traders at Aeglea Bio Therapeutics Inc are: Anthony G Quinn, Jonathan Alspaugh, Bioventures Ltd Novartis, Charles N York II, Armen Shanafelt, Orbimed Advisors Llc, Anthony G. Quinn, Anthony Quinn, Marcio Souza, and Aaron Schuchart
The most active insider trader at Aeglea Bio Therapeutics Inc is Anthony G Quinn with 15 trades.
Bioventures Ltd Novartis has sold the most Aeglea Bio Therapeutics Inc stock with a total value of $1,654,039.48.
Bioventures Ltd Novartis has bought the most Aeglea Bio Therapeutics Inc stock with a total value of $6,000,000.00.
The most recent insider trade for Aeglea Bio Therapeutics Inc was on Aug. 25, 2022.
The single biggest insider buy for Aeglea Bio Therapeutics Inc was from Bioventures Ltd Novartis with a total value of $3,000,000.00 on April 12, 2016.
The single biggest insider sell for Aeglea Bio Therapeutics Inc was from Bioventures Ltd Novartis with a total value of $748,424.60 on May 10, 2018.